MedCity News November 24, 2024
Synapticure’s Series A round was led by B Capital and included participation from CommonSpirit Health, CVS Health Ventures and RA Capital.
Synapticure, a virtual care company for neurodegenerative diseases, has secured $25 million in Series A funding to scale its services and expand its partnerships with health systems, payers and providers, it announced Tuesday.
Chicago-based Synapticure serves people and their families living with neurodegenerative diseases like Alzheimer’s, Parkinson’s and ALS. Its virtual platform provides access to neurologists, treatments, trials, care coordination services and behavioral health support. It works with health plans and providers and operates in all 50 states.
The Series A round was led by B Capital and included participation from CommonSpirit Health, CVS Health Ventures, RA Capital Management,...
Today's Sponsors
Today's Sponsor